UnitedHealth Group Incorporated: Beat — EPS $4.69, Revenue $112.69B
Earnings BeatQ3 2026 · Pre-market
@trystockwhiz
Did UnitedHealth Group Incorporated (UNH) beat earnings today?
Yes, UnitedHealth Group Incorporated (UNH) beat Wall Street analyst expectations for Q3 2026, reporting higher-than-expected EPS and higher-than-expected revenue.
Earnings Per Share+13.29% surprise
$4.69Actual
Expected: $4.14
vs. year ago +60.6%
Total Revenue+1.08% surprise
$112.69BActual
Expected: $111.49B
vs. year ago -0.4%
Released Oct 13 · 5:55 AM ET
Earning Report
| Metric | Q3 2026 | Q3 2025 | YoY Change % |
|---|---|---|---|
| Revenue | $112.69B | $113.16B | -0.4% |
| └─Premiums | $87.08B | $88.98B | -2.1% |
| └─Products | $14.29B | $13.30B | +7.5% |
| └─Services | $10.25B | $9.75B | +5.0% |
| └─Investment and other income | $1.08B | $1.13B | -4.9% |
| └─UnitedHealthcare | $86.33B | $87.07B | -0.8% |
| └─Optum | $66.88B | $69.18B | -3.3% |
| └─Optum Health | $22.91B | $25.42B | -10.0% |
| └─Optum Insight | $5.47B | $5.32B | +3.0% |
| └─Optum Rx | $39.93B | $39.68B | +0.6% |
| └─Employer & Individual | $20.21B | $19.88B | +1.7% |
| └─Medicare & Retirement | $42.42B | $43.36B | -2.2% |
| └─Community & State | $23.70B | $23.84B | -0.6% |
| GAAP Diluted EPS | $4.56 | $2.59 | +76.1% |
| Adjusted Diluted EPS | $4.69 | $2.92 | +60.6% |
| Net earnings | $4.30B | $2.54B | +69.1% |
Financial Outlook / Guidance
| Metric | Next Quarter Outlook | FY 2026 Outlook |
|---|---|---|
| Diluted earnings per share | — | At least $19.50 |
| Adjusted diluted earnings per share | — | At least $20.50 |
Business Highlights
- ➤Committed $1 billion to the refreshed United Health Foundation.
- ➤Supported 1,500 rural hospitals by accelerating payments and halving reimbursement timelines.
- ➤Announced nationwide doula care coverage expansion for employer-sponsored plans.
- ➤Expanded child and family behavioral health coaching access to approximately 13 million members.
- ➤Eliminating 30% of current prior-approval volume by year-end 2026.
- ➤Eliminating nearly two-thirds of prior-approval requirements for pediatric care.
- ➤Launched a fully transparent, fee-based pharmacy care model.
- ➤Committed to 100% pass-through of manufacturer drug rebate discounts by January 1, 2028.
- ➤Eliminated 33% of drug reauthorizations for nearly 270 chronic-condition medications.
- ➤Created a new Public Responsibility Committee and added an independent director.
- ➤Published comprehensive business-practice reviews and implemented all recommended improvements.
- ➤Repurchased $5.0B of common stock and paid $6.2B in dividends year-to-date.
Management Commentary
Stephen Hemsley, chief executive officer of UnitedHealth Group
“Our third quarter results reflect the discipline and execution our teams are bringing to every part of our business, as we continue evolving UnitedHealth Group to deliver a simpler, more supportive experience for patients and the clinicians who care for them,”